
Current Price | $192.91 | Mkt Cap | $10.8B |
---|---|---|---|
Open | $190.49 | P/E Ratio | 65.01 |
Prev. Close | $192.91 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $189.19 - $196.60 | Volume | 350,811 |
52-Wk Range | $137.21 - $262.26 | Avg. Daily Vol. | 507,173 |
A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.
Current Price | $192.91 | Mkt Cap | $10.8B |
---|---|---|---|
Open | $190.49 | P/E Ratio | 65.01 |
Prev. Close | $192.91 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $189.19 - $196.60 | Volume | 350,811 |
52-Wk Range | $137.21 - $262.26 | Avg. Daily Vol. | 507,173 |
The best Bull and Bear pitches based on recency and number of recommendations.
https://www.fool.com/investing/2022/01/20/2-healthcare-stocks-that-could-help-set-you-up-for/
These medical corporations tend to have spurts of large growth with long periods of notable decline. Just as Genetic Technologies as been fluctuating over the past year (a range from ~$2.50 - ~$10.00), this company follows a very similar trend. It… More
Read the most recent pitches from players about RGEN.
Recs
https://www.fool.com/investing/2022/01/20/2-healthcare-stocks-that-could-help-set-you-up-for/
Recs
10000000146
Recs
RGEN is often taken as a normal biotech. It ain't. It's product is in most cases the raw material, reagent, or quality control for the process used by a biotech company to produce product. And in most cases must be resupplied over time. In effect it produces the "blades" for the razors the biotechs produce. The notion changes risk/reward calculus. Evidence history of performance.
Find the members with the highest scoring picks in RGEN.
Stevegoldenfool (20.78) Score: +5,580.81
The Score Leader is the player with the highest score across all their picks in RGEN.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Stevegoldenfool | 20.78 | 9/26/2011 |
![]() |
5Y | $3.22 | +5,840.06% | +259.25% | +5,580.81 | 0 Comment | |
TXawlman | 98.09 | 10/26/2006 |
![]() |
5Y | $3.37 | +5,577.35% | +215.66% | +5,361.70 | 1 Comment | |
toroandbruin | 80.78 | 10/25/2006 |
![]() |
1Y | $3.37 | +5,575.67% | +216.03% | +5,359.64 | 0 Comment | |
sincroton | < 20 | 8/25/2006 |
![]() |
1Y | $3.36 | +5,592.56% | +238.75% | +5,353.81 | 1 Comment | |
warbucks52 | < 20 | 8/25/2006 |
![]() |
1Y | $3.36 | +5,592.56% | +238.92% | +5,353.64 | 0 Comment | |
runic42 | < 20 | 10/2/2006 |
![]() |
1Y | $3.40 | +5,525.59% | +227.33% | +5,298.26 | 0 Comment | |
Vanter1 | 99.55 | 11/11/2011 |
![]() |
5Y | $3.41 | +5,509.09% | +224.84% | +5,284.25 | 0 Comment | |
marky985 | < 20 | 10/27/2008 |
![]() |
3Y | $3.32 | +5,661.14% | +388.39% | +5,272.76 | 0 Comment | |
youmustwhipit | 75.27 | 10/27/2008 |
![]() |
NS | $3.32 | +5,661.14% | +388.39% | +5,272.76 | 0 Comment | |
wonderpiks | 96.82 | 5/6/2010 |
![]() |
5Y | $3.42 | +5,492.69% | +254.15% | +5,238.54 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.